Figure 1. Oligonol suppresses the frequency of IL-6-and TNF-α-expressing monocytes in human peripheral blood mononuclear cells (PBMCs) in response to LPS without inducing cell death.
PBMCs were purified from the peripheral blood of healthy human adults. (A–C) PBMCs were pre-incubated for 60 min with or without Oligonol (0–25 μg/ml) followed by an additional 5-hour incubation with or without LPS (500 ng/ml) in the presence of GolgiPlug. Incubated cells were analyzed for monocytes (CD14+) producing IL-6 and TNF-α using flow cytometry. (A) Dot plots show cells expressing cytokines in monocytes. (B–C) The frequency of IL-6- and TNF-α-expressing cells in monocytes is shown. (D–E) PBMCs were incubated for 6 hours in the presence or absence of Oligonol (0–25 μg/ml) or 10% DMSO (positive control for cell death). Cells were stained with annexin V and 7-AAD followed by flow cytometric analysis for live and dead cells. (D) Dot plots show live (annexin V−, 7-AAD−) and dead cells. (D) The frequency of live cells in monocytes. Numbers in dot plots indicate the frequency of cytokine expressing cells or cells stained or unstained with annexinV and/or 7-AAD. (A, D) representative data from 3 independent experiments with 3 donors. (B, C, E) data from 3 donors. Bars and error bars indicate mean and standard error of mean (SEM), respectively. *P < 0.05.